SL
Sudan Loganathan Stephens & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
7.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $30 |
66%
upside
| 3 | +40% |
0
%
| 4 Mar ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $100 |
17%
upside
| 2 | -4.9% |
0
%
| 2 Mar ‘26 3 months ago |
|
|
|
Overweight
Initiated
| $95 |
10%
upside
| 1 | -5.5% |
0
%
| 17 Dec ‘25 6 months ago |
|
|
|
Overweight
Reiterated
| $15 |
75%
upside
| 2 | -5.3% |
0
%
| 8 Dec ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $8 |
360%
upside
| 1 | -65% |
0
%
| 24 Nov ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $15 |
100%
upside
| 2 | +28% |
0
%
| 10 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $18 |
53%
upside
| 2 | -13% |
0
%
| 5 Nov ‘25 7 months ago |
|
|
|
Overweight
Initiated
| $35 |
12%
downside
| 1 | +14% |
0
%
| 28 Oct ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| $6 |
57%
upside
| 2 | +3.9% |
0
%
| 22 Sep ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| $45 |
49%
upside
| 1 | +48% |
0
%
| 9 Sep ‘25 9 months ago |
|
|
|
Overweight
Reiterated
| $30 |
76%
upside
| 1 | +17% |
0
%
| 10 Jul ‘25 11 months ago |
|
|
|
Overweight
Upgraded
| $60 |
13%
upside
| 1 | -5.2% |
0
%
| 24 Jun ‘25 11 months ago |
|